Protective Immunization against Group B Meningococci Using Anti-Idiotypic Mimics of the Capsular Polysaccharide

Journal of Immunology

Volumn 172, Issue 4, 2004, Pages 2461-2468

  Beninati, Concetta ^a   Arseni, Simona ^b   Mancuso, Giuseppe ^a   Magliani, Walter ^b   Conti, Stefania ^b   Midiri, Angelina ^a   Biondo, Carmelo ^a   Polonelli, Luciano ^b   Teti, Giuseppe ^a,c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; EPITOPE; IMMUNOGLOBULIN G2A; MENINGOCOCCUS GROUP B CAPSULAR POLYSACCHARIDE VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; POLYSIALIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL MENINGITIS; CHEMICAL MODIFICATION; CONTROLLED STUDY; CROSS REACTION; FEMALE; IMMUNIZATION; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PASSIVE IMMUNIZATION; PHAGE DISPLAY; PRIORITY JOURNAL; RABBIT; SEROTYPING; SPLEEN CELL; TH1 CELL;

EID: 0842278634     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.4.2461     Document Type: Article

References (32)

1. Jones, D. 1995. Epidemiology of meningococcal disease in Europe and the USA. In Meningococcal Disease. K. Cartwright, ed. John Wiley & Sons, New York, pp. 147-175.
2. Naess, A., A. Halstensen, H. Nyland, S. H. Pedersen, P. Moller, R. Borgmann, J. L. Larsen, and E. Haga. 1994. Sequelae one year after meningococcal disease. Acta Neurol. Scand. 89:139.
3. Klein, N. J., C. A. Ison, M. Peakman, M. Levin, S. Hammerschmidt, M. Frosch, and R. S. Heyderman. 1996. The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J. Infect. Dis. 173:172.
4. Frasch, C. E., W. D. Zollinger, and J. T. Poolman. 1985. Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis. 7:504.
5. Granoff, D. M., B. Forrest, and R. Rappuoli. 1997. Meningococcal polysaccharide-protein conjugate vaccines. Int. J. Infect. Dis. 1:152.
6. Finne, J., M. Leinonen, and P. H. Mäkelä. 1983. Antigenic similarities between brain components and bacteria causing meningitis: implications for vaccine development and pathogenesis. Lancet 2:355.
7. Jennings, H. J. 1997. N-propionylated group B meningococcal polysaccharide glycoconjugate vaccine against group B meningococcal meningitis. Int. J. Infect. Dis. 1:158.
8. Coquillat, D., J. Bruge, B. Danve, M. Latour, C. Hurpin, D. Schulz, P. Durbec, and G. Rougon. 2001. Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate. Infect. Immun. 69:7130.
9. Granoff, D. M., A. Bartoloni, S. Ricci, E. Gallo, D. Rosa, N. Ravenscroft, V. Guarnirei, R. C. Seid, A. Shan, W. R. Usinger, et al. 1998. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J. Immunol. 160:5028.
10. Shin, J. S., J. S. Lin, W. Anderson, R. A. Insel, and M. H. Nahm. 2001. Monoclonal antibodies specific for Neisseria meningitidis group B polysaccharide and their peptide mimotopes. Infect. Imm. 69:3335.
11. Pon, R. A., M. Lussier, Q. L. Yang, and H. J. Jennings. 1997. N-propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J. Exp. Med. 185:1929.
12. Moe, G. R., S. Tan, and D. M. Granoff. 1999. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immun. Med. Microbiol. 26:209.
13. McNamara, M., R. E. Ward, and H. Kohler. 1984. Monoclonal idiotype vaccine against Streptococcus pneumoniae infection. Science 226:1325.
14. Stein, K. E., and T. Soderstrom. 1984. Neonatal administration of idiotype or anti-idiotype primes for protection against E. coli K13 infection in mice. J. Exp. Med. 160:1001.
15. Westerink, M. A. J., A. A. Campagnari, M. A. Wirth, and M. A. Apicella. 1988. Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56:1120.
16. Magliani, W., L. Polonelli, S. Conti, A. Salati, P. F. Rocca, V. Cusumano, G. Mancuso, and G. Teti. 1998. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes. Nat. Med. 4:705.
17. Stephens, D. S., J. S. Swartley, S. Kathariou, and S. A. Morse. 1991. Insertion of Tn916 in Neisseria meningitidis resulting in loss of group B capsular polysaccharide. Infect. Immun. 59:4097.
18. 197 via adipic acid dihydrazide. Vaccine 13:463.
19. Magliani, W., S. Conti, F. De Bernardis, M. Gerloni, D. Bertolotti, P. Mozzoni, A. Cassone, and L. Polonelli. 1997. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity. Nat. Biotechnol. 15:155.
20. Beninati, C., M. R. Oggioni, M. Boccanera, M. R. Spinosa, T. Maggi, S. Conti, W. Magliani, F. De Bernardis, G. Teti, A. Cassone, et al. 2000. Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria. Nat. Biotechnol. 18:1060.
21. Mancuso, G., F. Tomasello, C. von Hunolstein, G. Orefici, and G. Teti. 1994. Induction of tumor necrosis factor alpha by the group and type-specific polysaccharide from type III group B streptococci. Infect. Immun. 62:2748.
22. Mandrell, R. E., F. H. Azmi, and D. M. Granoff. 1995. Complement-mediated bactericidal activity of human antibodies to poly α 2-8 N-acetyl neuraminic acid, the capsular polysaccharide of Neisseria meningitidis serogroup B. J. Infect. Dis. 172:1279.
23. Glick, M. C., B. D. Livingston, G. W. Shaw, J. L. Jacobs, and F. A. Troy. 1991. Expression of polysialic acid on human neuroblastoma. Prog. Clin. Biol. Res. 366:267.
24. Rubinstein, L. J., B. Goldberg, J. Hiernauz, K. E. Stein, and C. A. Bona. 1983. Idiotype-antiidiotype regulation: the requirement for immunization with antigen and monoclonal antiidiotypic antibodies for the activation of β2→6 and β2→1 polyfructan reactive clones in BALB/c mice treated at birth with minute amounts of anti-A48 idiotype antibodies. J. Exp. Med. 158:1129.
25. Schreiber, J. R., G. B. Pier, M. Grout, K. Nixon, and M. Patawaran. 1991. Induction of opsonic antibodies to Pseudomonas aeruginosa mucoid exopolysaccharide by an anti-idiotypic monoclonal antibody. J. Infect. Dis. 164:507.
26. Westerink, M. A. J., P. C. Giardina, M. A. Apicella, and T. Kieber-Emmons. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:4021.
27. Agadjanyan, M., P. Luo, M. A. Westerink, L. A. Carey, W. Hutchins, Z. Steplewski, D. B. Weiner, and T. Kieber-Emmons. 1997. Peptide mimicry of carbohydrate on human immunodeficiency virus. Nat. Biotechnol. 15:547.
28. Buchanan, R. M., B. P. Arulanandam, and D. W. Metzger. 1998. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J. Immunol. 161:5525.
29. Peeters, C. C., A. M. Tenbergen-Meekes, J. T. Poolman, M. Beurret, B. J. Zegers, and G. T. Rijkers. 1991. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect. Immun. 59:3504.
30. Kieber-Emmons, T., B. Monzavi-Karbassi, B. Wang, P. Luo, and D. B. Weiner. 2000. Cutting edge: DNA immunization with minigenes of carbohydrate mimotopes induce functional anti-carbohydrate antibody response. J. Immunol. 165:623.
31. Beninati, C. and G. Teti. 2000. A meeting of mimics, Trends Microbiol. 8:492.
32. Pizza, M., V. Scarlato, V. Masignani, M. M. Giuliani, B. Arico, M. Comanducci, G. T. Jennings, L. Baldi, E. Bartolini, B. Capecchi, et al. 2000. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816.